American Honda Receivables LLC is issuing $2,105,270,000 of asset‑backed notes spanning five classes, with coupon rates from 3.964% to 4.62% and a SOFR‑plus‑0.32% tranche. The issuance furnishes the company with fresh funding tied to new and used Honda and Acura loan receivables, expanding investor exposure to a high‑quality consumer finance portfolio.

Key Highlights

  • Five note classes total $2,105,270,000 in principal, each bearing distinct coupon rates.
  • American Honda Finance Corporation will retain at least 5% of each class, meeting risk‑retention rules.
  • The notes are secured by a pool of retail installment contracts on Honda and Acura vehicles.
  • Closing is set for August 12, 2026, when the notes will be delivered to underwriters.

American Honda Receivables LLC announced a $2,105,270,000 issuance of asset‑backed securities, split into five distinct classes. The spread of coupons provides investors with tiered yield options while funding a pool of Honda auto loan receivables. The breadth of the issuance underscores the firm’s strategy to diversify financing sources and lock in capital for upcoming loan originations.

Multi‑Class Note Structure

The note suite is organized by coupon tier, with the lowest‑rated Class A‑1 carrying a 3.964% rate and the highest‑rated Class A‑4 at 4.62%. The floating‑rate Class A‑2b is tied to SOFR plus 0.32%, offering a hedge against rising short‑term rates. By stratifying the capital raise, the company can attract investors with varying risk appetites while preserving the overall credit profile of the underlying receivables.

This design also aligns yield expectations with the projected cash‑flow characteristics of the vehicle loan pool, enhancing pricing efficiency. Consequently, investors must assess which tranche best matches their return targets and sensitivity to interest‑rate movements.

Retention and Risk‑Retention Compliance

American Honda Finance Corporation, the sponsor, will retain a minimum of 5% of the initial principal for each note class. This retention satisfies the SEC’s risk‑retention rule, ensuring the sponsor maintains a meaningful stake in the securities’ performance. The retained interest also signals confidence in the underlying collateral, which consists of new and used Honda and Acura installment contracts.

By holding a direct financial interest, the sponsor aligns its incentives with noteholders, potentially lowering perceived credit risk. The retention framework therefore offers an additional layer of protection for investors, who can rely on the sponsor’s vested commitment to the asset pool’s health.

Collateral and Servicing Framework

American Honda Finance Corporation will serve as the servicer, responsible for collecting payments and managing the underlying assets. A comprehensive Sale and Servicing Agreement governs the transfer of receivables to the trust and outlines servicing obligations, while an Asset Representations Review Agreement ensures ongoing verification of the receivables’ quality. This strong structure aims to preserve the cash‑flow predictability essential for timely interest and principal payments to noteholders.

Investors therefore benefit from a clear, enforceable chain of title and servicing responsibilities that support the securities’ credit integrity.

Forward Catalyst: Closing on August 12

The issuance will be finalized on or about August 12, 2026, when the notes are delivered to the underwriters and the underlying receivables are transferred into the trust. This closing event will trigger the first tranche of funding for the company and commence the scheduled interest payments to investors. Market participants will watch the closing closely, as any deviation could affect the timing of cash‑flow availability and the subsequent performance of the asset‑backed securities.

Analysis based on the Form 8-K filed 6 August 2026; figures verified against the filing.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.